Live from the Amsterdam Customer Experience lab: Gene Expression you can count on with nCounter®️


Connect next February 15th to hear how NanoString’s nCounter technology provides highly multiplexed, direct, digital expression data of mRNA, miRNA, lncRNA, fusion genes or DNA.

nCounter panels profile up to 800 targets simultaneously, workflow completed in less than 1.5 days, with no amplification, no library prep, no RT reactions required for standard protocols. Compatible with Total RNA, FFPE, cell lysate, PBMC, plasma, serum and more. Simple, streamlined data analysis solutions are available using our free nSolver software, and the technology is currently featured in > 4,000 publications.

During this webinar, you will hear success stories from scientists who will share how nCounter was instrumental in their journey to obtain valuable transcriptomic data from precious samples to ready-to-publish results:

– Johan van Weyenbergh will tell us about leveraging nCounter immunovirological screening to define clinically relevant biomarkers for fatal COVID-19 as well as long COVID

– Olivia Rifai will share how she used the nCounter neuroinflammation panel to profile neuroinflammatory signatures in the amyotrophic lateral sclerosis brain


Circular portrait of Amanda Mason

Amanda Mason, PhD

Field Application Scientist, NanoString

Johan van Weyenberg

Researcher, Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Leuven

Olivia Rifai

Post-doctoral fellow , Centre for Clinical Brain Sciences, University of Edinburgh. Current affiliation: Department of Neurology, Columbia University